Massachusetts General Hospital Cancer Center

https://www.massgeneral.org/cancer-center

 

Massachusetts General Hospital Cancer Center
J

Practice-Changing Updates in Indolent B-Cell Lymphomas

By Massachusetts General Hospital Cancer Center FEATURING Jake Soumerai
By Massachusetts General Hospital Cancer Center FEATURING Jake Soumerai
344 views
June 5, 2024

Chapters

Approved BTK Inhibitors in CLL & Novel Combinations

00:00

Comparing Zanubrutinib & Ibrutinib in CLL Patients

05:10

Noncovalent BTK Inhibitor Pirtobrutinib Clinical Results

10:32

Approach to Treating Refractory CLL

14:59

Venetoclax & Obinutuzumab as CLL Frontline Therapy

16:15

Venetoclax-Based vs. BTK Inhibitor-Based Treatment Strategies

17:44

Emerging Therapies for Triple Refractory CLL

17:54

Personalizing CLL Treatment With BOVen

19:58

TP53 Mutated Mantle Cell Lymphoma & BOVen Study

21:40

0 Comments
Login to view comments. Click here to Login
Changing Updates in Hematologic Malignancies
17:37
Massachusetts General Hospital Cancer Center

Experts Discuss Choosing BTKis in CLL, Sequencing Therapy in NHL, an…

Feat. J. Soumerai, J. Erika Haydu
25:47
Massachusetts General Hospital Cancer Center

Practice-Changing Updates in Indolent B-Cell Lymphomas

Feat. J. Soumerai
29:26
Massachusetts General Hospital Cancer Center

Practice-Changing Updates in DLBCL and HL

Feat. J. Erika Haydu